Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

α2-Macroglobulin Capture Allows Detection Of Mast Cell Chymase In Serum And Creates A Reservoir Of Angiotensin II-Generating Activity1

W. Raymond, S. Su, A. Makarova, T. M. Wilson, M. Carter, D. Metcalfe, G. Caughey
Published 2009 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Human chymase is a highly efficient angiotensin II-generating serine peptidase expressed by mast cells. When secreted from degranulating cells, it can interact with a variety of circulating antipeptidases, but is mostly captured by α2-macroglobulin, which sequesters peptidases in a cage-like structure that precludes interactions with large protein substrates and inhibitors, like serpins. The present work shows that α2-macroglobulin-bound chymase remains accessible to small substrates, including angiotensin I, with activity in serum that is stable with prolonged incubation. We used α2-macroglobulin capture to develop a sensitive, microtiter plate-based assay for serum chymase, assisted by a novel substrate synthesized based on results of combinatorial screening of peptide substrates. The substrate has low background hydrolysis in serum and is chymase-selective, with minimal cleavage by the chymotryptic peptidases cathepsin G and chymotrypsin. The assay detects activity in chymase-spiked serum with a threshold of ∼1 pM (30 pg/ml), and reveals native chymase activity in serum of most subjects with systemic mastocytosis. α2-Macroglobulin-bound chymase generates angiotensin II in chymase-spiked serum, and it appears in native serum as chymostatin-inhibited activity, which can exceed activity of captopril-sensitive angiotensin-converting enzyme. These findings suggest that chymase bound to α2-macroglobulin is active, that the complex is an angiotensin-converting enzyme inhibitor-resistant reservoir of angiotensin II-generating activity, and that α2-macroglobulin capture may be exploited in assessing systemic release of secreted peptidases.
This paper references
10.1096/fasebj.6.15.1281457
α2“Macroglobulin, a multifunctional binding protein with targeting characteristics
W. Borth (1992)
10.1016/S0167-4838(02)00224-8
Lys40 but not Arg143 influences selectivity of angiotensin conversion by human α-chymase
D. Muilenburg (2002)
10.1056/NEJM198706253162603
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
L. Schwartz (1987)
10.1136/jcp.56.2.103
Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study
H.-P. Horny (2003)
Highly efficient inhibition of human chymase by 2-macroglobulin
M. Walter (1999)
10.1016/J.JACI.2004.04.008
Effect of sex and haplotype on plasma tryptase levels in healthy adults.
H. Min (2004)
10.1016/J.PHARMTHERA.2006.05.008
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
M. Miyazaki (2006)
10.1161/01.CIR.99.8.1084
Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery.
N. Shiota (1999)
Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.
K. Beatty (1980)
10.1016/J.CLIM.2007.02.007
Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.
C. Akin (2007)
10.1016/s0021-9258(17)47234-6
Kinetics of association of human proteinases with human alpha 2-macroglobulin.
G. D. Virca (1984)
10.1097/00004872-200210000-00025
Transgenic study of the function of chymase in heart remodeling
L. Chen (2002)
10.1006/ABBI.1999.1309
Highly efficient inhibition of human chymase by alpha(2)-macroglobulin.
M. Walter (1999)
10.1074/jbc.M304087200
Albumin Is a Substrate of Human Chymase
W. Raymond (2003)
10.1291/hypres.30.349
The Significance of Chymase in the Progression of Abdominal Aortic Aneurysms in Dogs
K. Furubayashi (2007)
10.1016/J.JACI.2006.02.026
Tryptase genetics and anaphylaxis.
G. Caughey (2006)
10.1111/1523-1747.EP12264144
Angiotensin I conversion by human and rat chymotryptic proteinases.
B. Wintroub (1984)
10.1016/S0008-6363(03)00535-2
Impact of chymase inhibitor on cardiac function and survival after myocardial infarction.
D. Jin (2003)
10.1124/JPET.102.034231
Significance of Vascular Endothelial Cell Growth Factor Up-Regulation Mediated via a Chymase-Angiotensin-Dependent Pathway during Angiogenesis in Hamster Sponge Granulomas
J. Katada (2002)
10.1016/S1386-6346(02)00139-0
Establishment of an assay method for human mast cell chymase.
K. Satomura (2002)
Tryptase and chymase: comparison of extraction and release in two dog mastocytoma lines.
G. Caughey (1988)
10.1165/AJRCMB.18.6.2924
Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1.
S. Mckay (1998)
10.4049/jimmunol.170.11.5667
Tryptase Precursors Are Preferentially and Spontaneously Released, Whereas Mature Tryptase Is Retained by HMC-1 Cells, Mono-Mac-6 Cells, and Human Skin-Derived Mast Cells 1
L. Schwartz (2003)
10.1016/s0021-9258(18)50690-6
Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.
K. Nakajima (1979)
10.1074/jbc.M100223200
Dipeptidyl Peptidase I Is Essential for Activation of Mast Cell Chymases, but Not Tryptases, in Mice*
P. Wolters (2001)
10.1016/S0167-4838(00)00076-5
Angiotensin II generation by mast cell α- and β-chymases
G. Caughey (2000)
10.1007/s00414-005-0524-1
Usefulness of serum mast cell–specific chymase levels for postmortem diagnosis of anaphylaxis
H. Nishio (2005)
Kinetics of association of serine proteinases with native and oxidized  1 - proteinase inhibitor and  1 - antichymotryp
K. Beatty (1980)
10.1074/jbc.M202714200
The Three-dimensional Structure of the Human α2-Macroglobulin Dimer Reveals Its Structural Organization in the Tetrameric Native and Chymotrypsin α2-Macroglobulin Complexes*
S. Kolodziej (2002)
Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor1
S. McKay (1998)
10.1161/HC3601.094304
Significance of Chymase-Dependent Angiotensin II–Forming Pathway in the Development of Vascular Proliferation
M. Nishimoto (2001)
10.1172/JCI119529
Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.
L. Dell'Italia (1997)
Mast cell chymase-like protease(s) modulates Escherichia coli lipopolysaccharide-induced vasomotor dysfunction in skeletal muscle in vivo.
H. Suzuki (1998)
10.1016/s0021-9258(18)34171-1
Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases.
C. Reilly (1982)
10.1021/BI00329A036
Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors.
T. Tanaka (1985)
10.1126/science.271.5248.502
Angiotensin II-Forming Activity in a Reconstructed Ancestral Chymase
U. Chandrasekharan (1996)
10.1016/s0021-9258(19)30080-8
Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors.
N. Schechter (1989)
Chymase as a proangiogenic factor: a possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model
M. Muramatsu (2000)
Kinetics of association of serine proteinases with native and oxidized 1-proteinase inhibitor and 1-antichymotrypsin
K. Beatty (1980)
10.1042/CS0510087
The disappearance of enzyme-inhibitor complexes from the circulation of man.
K. Ohlsson (1976)
10.1172/JCI20805
Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.
Ming Li (2004)
10.1073/pnas.131147598
Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice
H. Ju (2001)
Involvement of chymasemediated angiotensin II generation in blood pressure regulation
M. Li (2004)



This paper is referenced by
10.1016/j.ijbiomac.2015.11.043
Identification of a new alpha-2-macroglobulin: Multi-spectroscopic and isothermal titration calorimetry study.
A. Rehman (2016)
10.1002/jcp.24266
Alpha‐2‐macroglobulin: A physiological guardian
A. Rehman (2013)
10.1007/978-3-030-27820-5_1
Overview of Mast Cells in Human Biology
Dean D Metcalfe (2020)
10.1007/978-1-60327-951-2_6
Protease Mediators of Anaphylaxis
G. Caughey (2011)
10.1111/j.1476-5381.2012.02055.x
Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?
S. Heuston (2012)
This information is current as Lost Efficiency during Primate Evolution Cathepsin G Gained Tryptic Function but How Immune Peptidases Change Specificity :
Wilfred W. Raymond (2010)
10.1007/978-1-4419-9533-9_12
Mast cell proteases as protective and inflammatory mediators.
G. Caughey (2011)
10.1371/journal.pone.0125797
Regulation of Hepatocyte Growth Factor in Mice with Pneumonia by Peptidases and Trans-Alveolar Flux
W. Raymond (2015)
10.1007/s11906-014-0429-9
Angiotensin-(1-12): A Chymase-Mediated Cellular Angiotensin II Substrate
S. Ahmad (2014)
10.1016/j.pharmthera.2018.05.011
Therapeutic targeting of cathepsin C: from pathophysiology to treatment
B. Korkmaz (2018)
10.2174/157340212800505007
Impact of Mast Cell Chymase on Renal Disease Progression.
H. Wasse (2012)
10.1186/s40413-016-0094-3
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases
D. Metcalfe (2016)
10.1016/j.ijbiomac.2017.06.026
Conformational behavior of alpha-2-macroglobulin: Aggregation and inhibition induced by TFE.
A. Rehman (2017)
during Primate Evolution Tryptic Function but Lost Efficiency Specificity: Cathepsin G Gained How Immune Peptidases Change
C. Craik (2010)
10.4049/jimmunol.1002292
How Immune Peptidases Change Specificity: Cathepsin G Gained Tryptic Function but Lost Efficiency during Primate Evolution
W. Raymond (2010)
10.1111/j.1525-139X.2011.00921.x
Increased Plasma Chymase Concentration and Mast Cell Chymase Expression in Venous Neointimal Lesions of Patients with CKD and ESRD
H. Wasse (2011)
10.1074/jbc.M112.449033
Mutational Tail Loss Is an Evolutionary Mechanism for Liberating Marapsins and Other Type I Serine Proteases from Transmembrane Anchors*
K. Raman (2013)
10.1172/JCI58815
The αvβ6 integrin modulates airway hyperresponsiveness in mice by regulating intraepithelial mast cells.
K. Sugimoto (2012)
10.1165/rcmb.2009-0324RT
Mast cell peptidases: chameleons of innate immunity and host defense.
N. Trivedi (2010)
Haematopoietic Serine Proteases : A Cleavage Specificity Analysis
Michael Thorpe (2014)
Untersuchung der proteolytischen Prozessierung von humanen Angiotensin-Peptiden
D. Hildebrand (2013)
10.1016/j.ejphar.2015.04.045
Mast cell proteases as pharmacological targets.
G. Caughey (2016)
10.1002/mrd.22817
Alpha‐2 macroglobulin as a region‐specific secretory protein in male reproductive tract, and its dynamics during sperm transit toward the female spermatheca in the blue crab
Thanyaporn Senarai (2017)
10.1021/acs.analchem.6b02073
Specific Light-Up Probe with Aggregation-Induced Emission for Facile Detection of Chymase.
Ruoyu Zhang (2016)
10.1007/978-3-319-46503-6_6
α2-Macroglobulins: Structure and Function.
I. Garcia-Ferrer (2017)
Effects of angiotensin-converting enzyme inhibitor therapy on the regulation of plasma and cardiac tissue renin-angiotensin system in heart transplant patientsGlobal RAS regulation in HTx
J. J. (2016)
10.1111/imr.12639
Biomarkers for evaluation of mast cell and basophil activation
K. Kabashima (2018)
10.1016/B978-0-12-382219-2.00590-1
Chapter 590 – Chymases
G. Caughey (2013)
Atheroinflammatory Properties of LDL and HDL Particles Modified by Human Mast Cell Neutral Proteases
Katariina Maaninka (2018)
10.1016/j.jaci.2019.02.004
Regulation of the pleiotropic effects of tissue-resident mast cells.
M. Huber (2019)
10.2147/JAA.S213016
IgE-Mediated Systemic Anaphylaxis And Its Association With Gene Polymorphisms Of ACE, Angiotensinogen And Chymase
V. Varney (2019)
10.1016/j.ijbiomac.2019.01.136
Biophysical analysis of interaction between curcumin and alpha-2-macroglobulin.
Syed Saqib Ali (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar